Zengjin Liu

6PUBLICATIONS
4CO-AUTHORS
Gene and molecular therapyChemotherapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Rehabilitation engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 10, 2026
Natural Product-Inspired PROTACs for Leukemia Therapy: Hederagenin-Driven Targeted Degradation of SKP2.

Lei Chen, Tao Bi, Juan Huang

|Dec 05, 2025
Synergistic Proteolysis Targeting Chimera Chemotherapy Conjugate for Potent Non-small Cell Lung Cancer Treatment.

Qixin Zhao, Rui Zeng, Tao Bi

|Mar 06, 2025
Targeted Degradation of Bromodomain-Containing Protein 4 Enabled by Reactive Oxygen Species-Activatable NanoPROTACs as an Efficient Strategy to Reverse Liver Fibrosis in Chronic Liver Injury.

Tao Bi, Pan Liang, Qixin Zhao

|Nov 12, 2024
Disruption of Ferroptosis Inhibition and Immune Evasion with Tumor-Activatable Prodrug for Boosted Photodynamic/Chemotherapy Eradication of Drug-Resistant Tumors.

Tao Bi, Qixin Zhao, Ting Wang

|Mar 22, 2024
Correction to "Rational Design of Bioorthogonally Activatable PROTAC for Tumor-Targeted Protein Degradation".

Tao Bi, Pan Liang, Yanan Zhou

|Oct 23, 2023
Rational Design of Bioorthogonally Activatable PROTAC for Tumor-Targeted Protein Degradation.

Tao Bi, Pan Liang, Yanan Zhou

Pageof 1

Frequent Collaborators

1 joint publications

Pan Liang

1 joint publications

Qixin Zhao

1 joint publications

Pei Luo

1 joint publications

Jun Bai